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Expanding the Landscape of Diterpene Structural Diversity through
Stereochemically Controlled Combinatorial Biosynthesis
Johan Andersen-Ranberg, Kenneth Thermann Kongstad, Morten Thrane Nielsen,
Niels Bjerg Jensen, Irini Pateraki, Søren Spanner Bach, Britta Hamberger, Philipp Zerbe,
Dan Staerk, Jçrg Bohlmann, Birger Lindberg Møller, and Bjçrn Hamberger*
Abstract: Plant-derived diterpenoids serve as important phar-
maceuticals, food additives, and fragrances, yet their low
natural abundance and high structural complexity limits their
broader industrial utilization. By mimicking the modularity of
diterpene biosynthesis in plants, we constructed 51 functional
combinations of class I and II diterpene synthases, 41 of which
are “new-to-nature”. Stereoselective biosynthesis of over 50
diterpene skeletons was demonstrated, including natural var-
iants and novel enantiomeric or diastereomeric counterparts.
Scalable biotechnological production for four industrially
relevant targets was accomplished in engineered strains of
Saccharomyces cerevisiae.
Diterpenoids are a diverse class of structurally complex
natural products with broad therapeutic applications. Plants
provide the major source of these chemicals and present a rich
reservoir of potentially new pharmaceuticals. Exploitation of
this diversity is severely limited by difficulties in extracting
pure compounds from natural sources on an industrial scale.
Alternatives include semisynthesis from naturally occurring
precursors, plant cell cultures, and chemical synthesis.[1]
Stereospecific synthetic routes for complex diterpenoids
often remain commercially impracticable owing to their low
efficiency.[2] Combinatorial metabolic engineering of micro-
bial or plant hosts, using the enzymes of the biosynthetic
pathways, offers an alternative environmentally benign access
to structurally complex diterpenoids with specific and novel
stereochemistry, which often defines the therapeutic value.[3]
The carbon skeletons of bi- and polycyclic labdanes and
clerodanes are formed in a two-step enzyme reaction
catalyzed by bifunctional class I/II diterpene synthases
(diTPSs) or pairs of distinct monofunctional diTPSs defined
by their catalytic activity as class I or class II enzymes.[4]
Class II diTPSs catalyze the initial cyclization of (E,E,E)-
geranylgeranyl diphosphate (GGPP) into bicyclic diphos-
phate intermediates with a characteristic decalin core
(Scheme 1). The structure and specific stereochemistry at
the C9 and C10 carbon atoms of the intermediate are
determined by the class II diTPS catalyzed reaction. The
subsequent class I diTPS reaction completes the formation of
the diterpene skeleton through dephosphorylation of the
class II product and specific rearrangements, additional
cyclizations, or water addition, thereby resulting in the
introduction of additional chiral centers (Scheme 1).[4b]
We have recently identified a diverse suite of 40 class II
and class I diTPSs from ten plant species, each harboring
structurally exceptional diterpenoids.[5] In plants, specific
pairs of class I and class II diTPSs form distinct diterpene
skeletons, which underpins the structural diversity of native
diterpenoids.[6] To explore the inherent metabolic potential
and plasticity of modular combinations of diTPSs, we system-
atically paired diTPSs through co-expression in heterologous
hosts. Specifically, we probed the substrate and product
plasticity for every combination of eleven class II and nine
class I diTPSs representative of diverse plant species and
potential functionalities. Eight functionally uncharacterized
diTPSs were included in this approach (Table S1 in the
Supporting Information).
We report herein the stereoselective formation of more
than 50 labdane- and clerodane-type skeletons through the
assembly of combinations of diTPS pairs. These skeletons are
labelled throughout (1–47) according to their Kovats reten-
tion indices (Figure S1–4 and Table S2 in the Supporting
Information). The a and b suffixes indicate (+) or ent
configurations, respectively, as shown by chiral GC–MS
analysis, NMR, and optical rotation measurements of selected
purified compounds. Three examples illustrate the potential
of this approach for control of the stereochemical config-
uration of diterpenes through specific selection of class II
diTPSs and for extension of the known structural repertoire
of skeletons accessible by biosynthesis through combination
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with class I diTPSs. A list of all of the diterpenes produced is
given in Table S2.
DiTPS combinations were tested by Agrobacterium
tumefaciens mediated transient expression in Nicotiana
benthamiana and the results were supported by in vitro
assays with recombinant diTPS expressed and purified from
E. coli for each type of class II diTPS. To demonstrate
fermentation-based diterpene production, selected diTPS
combinations were introduced into engineered Saccharomy-
ces cerevisiae to yield target molecules at a scale relevant for
industrial consideration.
Comparison of substrate and product profiles showed that
the class I diTPSs show distinct degrees of substrate and
product plasticity with regards to the stereochemistry and
hydroxylation pattern of the diphosphate substrate. Specifi-
cally, in a total of 12 combinations, a subset of six class I
diTPSs converted the two stereoisomers of labda-13-en-8-ol
diphosphate [(+)-8-LPP and ent-8-LPP, Figure 1].
The discrete formation of three stereoisomers of the
diterpene manoyl oxide highlights how biosynthetic routes
can be stereoselectively controlled (Figure 2). (13R)-
(+)-manoyl oxide (16a), a precursor for the diterpenoid
pharmaceutical forskolin,[6a] was formed from (+)-8-LPP by
the combination of Salvia sclarea SsLPPS with Marrubium
vulgare MvTPS5 at 3.7 times higher levels than the native
combination of CfTPS2 and CfTPS3 from Coleus forskohlii,
which may be relevant for future production. Stereoselective
access to manoyl oxide stereoisomers is a prerequisite for the
biotechnological production of forskolin derivatives with
novel stereochemical configurations. In combination with
the class II diTPS TwTPS21 from Tripterygium wilfordii,
CfTPS3 catalyzed the stereoselective formation of (13R)-ent-
manoyl oxide (16b). Combination of the class I diTPS
TwTPS2 with CfTPS14 or Euphorbia peplus EpTPS1, which
are unable to convert (+)-8-LPP, enabled the stereoselective
biosynthesis of the diastereomer (13S)-ent-manoyl oxide
(20b ; Figure 2 and Figure S16). The ent-configuration of
compounds 16b and 20b is consistent with a function of the
class II diTPS TwTPS21 in providing specifically
(5R,8S,9S,10S)-labda-13-en-8-ol diphosphate (ent-8-LPP),
a potential intermediate of bioactive diterpenoids with this
stereochemistry found in nature yet unknown in biosynthetic
routes.[8]
The formation of structurally distinct bicyclic diterpenes,
such as sclareol, which is used in high-end fragrance
manufacture, is catalyzed in S. sclarea by SsLPPS and
SsSCS.[9] Antibiotic activities have been reported for a com-
pound of this class, (+)-manool,[10] which is also recognized as
a starting material for the semisynthesis of a wide range of
diterpenoids with pharmaceutical properties.[11] SsSCS was
used as a representative of class I diTPSs that, following
rearrangement, facilitate neutralization of the carbocation
through water quenching at C13 to give regiospecific intro-
duction of a hydroxy group.[9] When offered the three known
stereoisomers of copalyl diphosphate (CPP), SsSCS formed
products with the stereochemistry preserved at the chiral
centers C9 and C10, as defined by the class II diTPSs.
Specifically, the pairing of SsSCS with diTPSs forming ent-
CPP, (+)-CPP, or syn-CPP, resulted in the stereoselective
formation of ent-manool (23b), (+)-manool (23a), and syn-
manool (11), respectively, both inN. benthamiana and in vitro
(Figure 2, Figure S16, and Tables S4,S5). Upon identification
of the new combination of diTPSs that efficiently yields 23a,
CfTPS1 and SsSCS were codon optimized and stably inte-
grated into the genome of a strain of S. cerevisiae engineered
for diterpene production to afford 23a at 310 mgL¢1
(Table S9), thereby effectively tripling previously reported
titers.[12]
The highly efficient conversion of bicyclic diphosphate
intermediates by SsSCS proved instrumental in elucidating
the function of an uncharacterized class II diTPS. The
combination of TwTPS14 with SsSCS produced a compound
consistent with a diTPS function new to plants and only
recently reported in the bacterium Herpetosiphon aurantia-
Scheme 1. The modular nature of diterpene biosynthesis. Overview of
class II and class I diTPSs and their products. The decalin core is
shown in bold. Zm=Zea mays; Cf=Coleus forskohlii ; Ss=Salvia
sclarea ; Os=Oryza sativa ; Mv=Marrubium vulgare, Tw=Tripterygium
wilfordii.
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cus.[13] Purification and NMR analysis established the struc-
ture as kolavelool (26), from the distinct class of clerodane-
type diterpenes (Table S6).[4b] These diterpenes have been
reported from a range of plant species and form the skeleton
of salvinorin A, a lead drug candidate for the treatment of
mental disorders and substance dependence,[14] yet the
biosynthetic route remains unknown. Similarly, coupling of
two functionally uncharacterized class II diTPSs with the nine
class I diTPSs and comparison of the product profiles with
those of established enzymes enabled the classification of
EpTPS7 and TwTPS7 as ent-CPP synthases (Figure 2).
Furthermore, combining ent-CPP synthases with EpTPS8 or
EpTPS23 resulted in the formation of ent-neoabietadiene and
ent-dehydroabietadiene, respectively (Figure S14), diterpene
scaffolds not previously reported in nature. Likewise, the
TwTPS21/SsSCS combination yielded ent-sclareol, which
constitutes the first biosynthetic route to this specific stereo-
isomer.
Several of the combinations provided skeletons of high-
value diterpenoids, for example, miltiradiene (25), the back-
bone of cardioprotectives (tanshinones)[15] and antioxidants
(carnosoic acid),[16] 16a and 23a as precursors for the drug
forskolin,[6a] and the synthetic ambergris substitute (¢)-
ambrox, which is used in high-end fragrances.[17] For stereo-
selective production of these targets, expression-optimized
variants of CfTPS1/CfTPS3, CfTPS2/CfTPS3, and TwTPS21/
EpTPS1 were introduced stably into the genome of a S.
cerevisiae strain engineered for diterpene production. Pro-
duction titers between 250–370 mgL¢1 (Table S9) underline
the potential for scale-up production by fermentation.
In summary, we show that engineered diTPS combina-
tions can be used to expand the biosynthetically accessible
repertoire of diterpene skeletons with superior stereochem-
ical control. Our approach meets a long-standing desire for
control over the stereochemical configuration of synthesized
diterpenes, which remains a challenge in formal chemical
synthesis. With chiral molecules representing more than half
of approved drugs worldwide, collectively valued at over $200
billion in 2008,[18] our findings make an important contribu-
tion to accelerate drug development and demonstrate how
synthetic biology can complement chemical synthesis for the
production of stereochemically complex small molecules.
Experimental Section
Generation of expression constructs, expression inN. benthamiana, S.
cerevisiae and E. coli, extraction analysis of products, and structural
elucidation by NMR were done as previously described and are given
in supplementary material and methods.[6a,19]
Figure 1. The diterpene chemoscape. A) Levels of diterpenes accumu-
lating in the N. benthamiana/Agrobacterium system (n=3). B) GC–MS
chromatograms of extracts from the N. benthamiana control, CfTPS1/
SsSCS expressed in N. benthamiana or in S. cerevisiae, the in vitro
assay, and an authentic standard of (9S,1(0S-manool (23a). Total ion
current (TIC) and extracted-ion chromatogram (EIC) levels are not to
scale. C) 2D representation of diterpenes detected in N. benthamiana
expressing either a single diTPS or combinations of diTPSs from the
two classes (y axis). Diterpenes are sorted on the x axis by their Kovats
retention indices. Cf=C. forskohlii ; Ss=S. sclarea; Mv=M. vulgare ;
Ep=Euphorbia peplus; Os=O. sativa ; Tw=T. wilfordii ; Zm=Z. mays.
Diterpenes in samples expressing solely class II diTPSs are likely the
result of endogenous phosphatase activity and non-specific rearrange-
ment (Figure S7).[6a, 7]
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Figure 2. Combinatorial wheel. Formation of diterpenes by natural and engineered diTPS combinations. Bonds in a specified stereochemical
configuration formed through stereoselective controlled synthesis are highlighted in red. Bonds in a specified stereochemical configuration for
which there is no biosynthetic access to the other configuration are shown in black. The a and b suffixes indicate (+) and ent configurations,
respectively, as dictated by the class II diTPS. Diterpenes with unknown structure are shaded in grey. * indicates clerodane diterpenes.
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